在GP IIb/IIIa-ICAM-1中介血小板-内皮粘附加剧肺高血压
Lingdan Chen1, Qianwen Bai1, Ruidi Tang1
1State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
American journal of respiratory cell and molecular biology
|February 28, 2025
概括
血小板通过粘附于内皮,激活和释放增长因子,使肺动脉变厚,从而导致肺高血压 (PH). 向血小板粘附分子可能为PH提供治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 血液学 血液学 血液学
- 肺部医学 肺部医学
背景情况:
- 肺高血压 (PH) 与血小板数量减少有关,但它们在疾病发病过程中的特定作用尚未完全理解.
- 血小板越来越多地被认为与血液静止之外的心血管疾病有关.
研究的目的:
- 研究血小板在肺高血压的发展和进展中的作用.
- 阐明血小板在PH中对肺血管重塑有所贡献的分子机制.
主要方法:
- 利用PH的动物模型,包括血小板枯竭和输血研究.
- 对PH患者和健康对照的血小板进行了转录基因分析.
- 研究了血小板糖蛋白IIb/IIIa (GP IIb/IIIa) 和细胞间粘附分子-1 (ICAM-1) 在肺动脉内皮细胞之间的相互作用.
- 评估了血小板衍生生长因子BB (PDGF-BB) 对肺动脉光滑肌细胞 (PASMC) 增殖和迁移的影响.
- 在PH的小鼠模型中评估了向ICAM-1的治疗潜力.
主要成果:
- 在PH模型中,血小板枯竭减少了肺血管厚,而PH血小板输血加剧了它.
- 来自PH患者的血小板显示了与细胞粘附和激活相关的基因升高调节,包括GP IIb/IIIa.
- 在内皮细胞上,GP IIb/IIIa介导的粘附于ICAM-1触发了血小板激活和PDGF-BB释放.
- PDGF-BB促进了PASMC的扩散和迁移,有助于血管加厚.
- 药理学向ICAM-1缓解PH在正常血栓缩小鼠中,但不是在血栓缩小鼠中.
结论:
- 通过GP IIb/IIIa和ICAM-1调解的血小板对肺内皮的粘附是PH的关键驱动因素.
- 血小板激活和随后的PDGF-BB分泌促进肺血管重塑和疾病进展.
- 准血小板-内皮相互作用代表了管理肺高血压的潜在治疗途径.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
142
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
142
01:31Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K
01:17Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
01:22Formation of the Platelet Plug
3.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.7K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
126
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
126
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
454
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
454